MYLAN INSTITUTIONAL FDA Approval ANDA 204949

ANDA 204949

MYLAN INSTITUTIONAL

FDA Drug Application

Application #204949

Application Sponsors

ANDA 204949MYLAN INSTITUTIONAL

Marketing Status

Prescription001

Application Products

001POWDER;INTRAVENOUS, SUBCUTANEOUS100MG/VIAL0AZACITIDINEAZACITIDINE

FDA Submissions

LABELING; LabelingORIG1AP2016-04-28STANDARD
LABELING; LabelingSUPPL2AP2019-02-12STANDARD
LABELING; LabelingSUPPL3AP2019-02-12STANDARD

Submissions Property Types

ORIG1Null1
SUPPL2Null7
SUPPL3Null15

TE Codes

001PrescriptionAP

CDER Filings

MYLAN INSTITUTIONAL
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204949
            [companyName] => MYLAN INSTITUTIONAL
            [docInserts] => ["",""]
            [products] => [{"drugName":"AZACITIDINE","activeIngredients":"AZACITIDINE","strength":"100MG\/VIAL","dosageForm":"POWDER;INTRAVENOUS, SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/28\/2016","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Labeling","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => [{"actionDate":"02\/12\/2019","submission":"SUPPL-3","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."},{"actionDate":"02\/12\/2019","submission":"SUPPL-2","supplementCategories":"Labeling-Package Insert","inserts":"[]","notes":"> Label is not available on this site."}]
            [actionDate] => 2019-02-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.